An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides

Heterocycle‐containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine‐derived enzymes and substrates obtained from a famil...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 53; no. 51; pp. 14171 - 14174
Main Authors Houssen, Wael E., Bent, Andrew F., McEwan, Andrew R., Pieiller, Nathalie, Tabudravu, Jioji, Koehnke, Jesko, Mann, Greg, Adaba, Rosemary I., Thomas, Louise, Hawas, Usama W., Liu, Huanting, Schwarz-Linek, Ulrich, Smith, Margaret C. M., Naismith, James H., Jaspars, Marcel
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 15.12.2014
WILEY‐VCH Verlag
Wiley
Wiley Subscription Services, Inc
EditionInternational ed. in English
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Heterocycle‐containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine‐derived enzymes and substrates obtained from a family of ribosomally produced and post‐translationally modified peptides called the cyanobactins. The substrate precursor peptide is engineered to have a non‐native protease cleavage site that can be rapidly cleaved. The other enzymes used are heterocyclases that convert Cys or Cys/Ser/Thr into their corresponding azolines. A macrocycle is formed using a macrocyclase enzyme, followed by oxidation of the azolines to azoles with a specific oxidase. The work is exemplified by the production of 17 macrocycles containing 6–9 residues representing 11 out of the 20 canonical amino acids. Heterocycle‐containing cyclic peptides are promising scaffolds for the pharmaceutical industry, but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine‐derived enzymes and substrates.
Bibliography:BBSRC - No. BB/K015508/1
Funded Access
TSB - No. 131181
This work was supported by grants from the Leverhulme Trust RPG-2012-504 (M.J., M.C.M.S., and J.H.N.), TSB 131181 (M.J., J.H.N., and W.E.H.), ERC 339367 (J.H.N. and M.J.) MSD-SULSA (M.J. and A.R.M.), BBSRC BB/K015508/1 (J.H.N. and M.J.). J.T. is funded by EU-FP7 contract Pharmasea 312184. W.E.H is the recipient of the SULSA Leaders award. We thank the BSRC mass spectrometry facility at the University of St Andrews and Aberdeen Proteomics Facility for extensive sample analysis. This research is funded in part by the MSD Scottish Life Sciences fund. As part of an on-going contribution to Scottish life sciences, Merck Sharp & Dohme (MSD) has given substantial monetary funding to the Scottish Funding Council (SFC) for distribution via the Scottish Universities Life Science Alliance (SULSA) The opinions expressed in this research article are those of the authors and do not necessarily represent those of MSD or its affiliates.
Leverhulme Trust - No. RPG-2012-504
ark:/67375/WNG-7H60SM6S-W
ERC - No. 339367
istex:3A738A10CEE461E10F99684B2D656869E2D68690
ArticleID:ANIE201408082
These authors contributed equally to this work.
This work was supported by grants from the Leverhulme Trust RPG‐2012‐504 (M.J., M.C.M.S., and J.H.N.), TSB 131181 (M.J., J.H.N., and W.E.H.), ERC 339367 (J.H.N. and M.J.) MSD‐SULSA (M.J. and A.R.M.), BBSRC BB/K015508/1 (J.H.N. and M.J.). J.T. is funded by EU‐FP7 contract
Pharmasea
312184. W.E.H is the recipient of the SULSA Leaders award. We thank the BSRC mass spectrometry facility at the University of St Andrews and Aberdeen Proteomics Facility for extensive sample analysis. This research is funded in part by the MSD Scottish Life Sciences fund. As part of an on‐going contribution to Scottish life sciences, Merck Sharp & Dohme (MSD) has given substantial monetary funding to the Scottish Funding Council (SFC) for distribution via the Scottish Universities Life Science Alliance (SULSA) The opinions expressed in this research article are those of the authors and do not necessarily represent those of MSD or its affiliates.
researchfish
UKRI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.201408082